Biomarin Pharmaceutical Inc

BMRN NASDAQ Santé & Biotech États-Unis US09061G1013
55.95 $
0.74 %

Biomarin Pharmaceutical Inc se concentre sur le développement et la commercialisation de traitements innovants pour des maladies génétiques rares.

Performance & Momentum

6 Months 7.35 %
1 Year 0.48 %
3 Years 40.95 %
5 Years 31.68 %

Similar stocks to Biomarin Pharmaceutical Inc

Anantys Community

Be the first to share your analysis on Biomarin Pharmaceutical Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases